2011
DOI: 10.1016/j.amepre.2011.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Insurance, Home Therapy, and Prophylaxis in U.S. Youth with Severe Hemophilia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 23 publications
(22 citation statements)
references
References 51 publications
0
22
0
Order By: Relevance
“…Previous research has consistently shown that being able to manage the child's treatment at home is essential to reduce the impact of the illness for both the child and the parent (Baker, Riske, Voutsis, Cutter, & Presley, ; Myrin Westesson et al, ; Myrin Westesson et al, ; Myrin Westesson et al, ; Stoffman et al, ; von der Lippe et al, ). Somewhat surprisingly, the findings revealed that when a family member administered the clotting factor to the child, the parental perceived burden was higher when compared to if a HCP administered the clotting factor.…”
Section: Discussionmentioning
confidence: 99%
“…Previous research has consistently shown that being able to manage the child's treatment at home is essential to reduce the impact of the illness for both the child and the parent (Baker, Riske, Voutsis, Cutter, & Presley, ; Myrin Westesson et al, ; Myrin Westesson et al, ; Myrin Westesson et al, ; Stoffman et al, ; von der Lippe et al, ). Somewhat surprisingly, the findings revealed that when a family member administered the clotting factor to the child, the parental perceived burden was higher when compared to if a HCP administered the clotting factor.…”
Section: Discussionmentioning
confidence: 99%
“…This suggested the influence of medical insurances and reimbursement policy played an important role in patients with prophylaxis, which had also been observed in the United States, though to a different scale. 25 Thus, although the management of haemophilia in China has undergone inspiring changes with some detectable achievements over the last decade, the joint bleeding in the study cohort was still very high, suggesting the poor affordability of clotting factor concentrates was the major challenge. Inability to afford continuous prophylaxis at least twice weekly for more than 12 weeks by some patients was precisely the reason why there were no eligible patients from Centre 1 in 2011 and 2013 ( Figure 3).…”
Section: Discussionmentioning
confidence: 99%
“…Home therapy was accepted as standard of care for all ages. 32,33 Prophylactic clotting factor replacement was recommended as the standard of care for children in the US, although widespread adoption of primary prophylaxis was slow during the time this group of men were children. …”
Section: Era D 1982-1993mentioning
confidence: 99%